Pregnancy and IBD

Most people with Crohn's or colitis can have a healthy pregnancy. Plan ahead, get into remission first, and keep taking safe medicines.

Reviewed October 2026 9 min read

At a glance

  • Talk to your IBD team before you try to get pregnant. The best time is when your IBD has been calm for at least 3 months. Start folic acid before you try, too.
  • Keep taking most IBD medicines, including biologics, through pregnancy and after birth. Do not stop on your own.
  • Some pills must stop 3 months before you try: methotrexate, JAK pills (tofacitinib, upadacitinib) and S1P pills (ozanimod, etrasimod). Your team will switch you to a safe medicine first.
  • Expect a stool test (calprotectin) and blood work about once each trimester, even when you feel well.
  • Most people with IBD can have a vaginal birth. A C-section is advised for active disease around the bottom, a past fistula into the vagina, or a J-pouch.
  • Breastfeeding is encouraged. Most IBD medicines are fine while breastfeeding. JAK and S1P pills are not.
  • If you took a biologic in pregnancy, tell your baby's doctor. Most vaccines, including rotavirus, can be given on time. Avoid BCG for the first 6 months.
  • Ask your obstetrician about low-dose aspirin, started at 12 to 16 weeks, to help prevent pre-eclampsia.
  • Get the flu shot, a COVID-19 vaccine and Tdap in pregnancy, and plan RSV protection for your baby. These are safe on IBD medicines.

The big picture

Most people with Crohn’s disease or ulcerative colitis can have a healthy pregnancy and a healthy baby.

The most important thing is to have your IBD calm (in remission) when you get pregnant, and to keep it calm. Active IBD is a bigger risk to a pregnancy than most IBD medicines are. When IBD is calm, pregnancy outcomes look much like those of people without IBD.

Dr. Squirell and her colleagues followed 287 women with IBD through 291 pregnancies at a specialist clinic in British Columbia. Here is what they found:

More than 9 in 10

pregnancies ended in a live birth.

About 7 in 100

babies came early. That is no higher than for other people in the province.
From Dr. Squirell's study of 291 pregnancies at the IBD Centre of BC, 2017 to 2023.
  • IBD that was active before pregnancy was the strongest sign that it would be active during pregnancy.
  • Babies whose mothers needed steroids for a flare were more likely to come early.
  • Biologic medicines did not change how the pregnancies turned out.

Before you try to get pregnant

Book a planning visit with your IBD team. Do this a few months before you start trying, if you can. At this visit, your team will:

  • Check that your IBD is truly calm, with tests like a stool test, blood work, an ultrasound or a scope.
  • Review each of your medicines.
  • Talk about vitamins, smoking, alcohol, and anything else that affects pregnancy.

Experts advise waiting until your IBD has been calm, without steroids, for at least 3 months.

Take folic acid, a B vitamin, every day. It helps prevent birth defects of the baby’s spine and brain. Start before you try to get pregnant. The dose depends on your medicines and on how well your bowel takes in food:

How much folic acid to take each day
Who Dose each day When
Most people with IBD 0.4 mg Start at least 1 month before you try. Keep taking it all through pregnancy.
On sulfasalazine 2 mg Start 3 months before you try. Keep taking it all through pregnancy.
Severe malabsorption 5 mg Start 3 months before you try. Keep taking it all through pregnancy.

“Most people” means you do not take sulfasalazine and your bowel takes in food well. Sulfasalazine makes it harder for your body to use folic acid. Malabsorption means your bowel cannot take in food well. This can happen with Crohn’s in a long part of the small bowel, or after a lot of small bowel surgery. If a close family member was born with spina bifida, your team may also advise a higher dose. Many prenatal vitamins have some folic acid in them, so ask your pharmacist how to reach your dose.

Fertility

Most people with calm IBD can get pregnant. Active IBD can make it harder. Surgery to make a J-pouch (the pouch made from the small bowel after the colon is removed) can also make it harder. If you have trouble getting pregnant, fertility treatments such as IVF seem to work about as well for people with IBD.

Your medicines

Most IBD medicines are safe in pregnancy. Do not stop them on your own. Stopping can cause a flare, and a flare is riskier for your baby than the medicine.

A few pills can harm a developing baby. They must stop 3 months before you try to get pregnant. Some of them leave your body sooner than that. But 3 months also gives time to switch you to a safe medicine and make sure the new one keeps your IBD calm.

Medicines you can usually keep taking

  • 5-ASA: mesalamine, sulfasalazine
  • Azathioprine, mercaptopurine
  • Anti-TNF: infliximab, adalimumab, golimumab with no break
  • Vedolizumab
  • Ustekinumab, risankizumab, mirikizumab, guselkumab
  • Prednisone, budesonide for a flare

Breastfeeding: yes, on all of these.

Medicines that must stop before you try

Stop at least this long before trying:

  • Methotrexate 3 months
  • JAK pills: tofacitinib, upadacitinib 3 months
  • Ozanimod 3 months
  • Etrasimod 3 months

Breastfeeding: no, not on any of these.

One stop time for all of them: 3 monthsThe 3 months covers the time to switch medicines and check that the new one works.
  • Methotrexate3 months
  • JAK pills3 months
  • Ozanimod3 months
  • Etrasimod3 months

Ozanimod and etrasimod are called S1P pills.

If you get pregnant while on one of the “stop” medicines, do not panic and do not just stop it. Call your IBD team the same day.

Will a biologic reach my baby?

Biologics cross the placenta mostly late in pregnancy. Your baby may still have some medicine in their blood for several months after birth. Studies have not shown harm to babies’ health or growth from this. Experts now advise taking biologics on schedule all through pregnancy, with no break near the end.

What if I have a flare while pregnant?

Call your IBD team right away. Flares can be treated in pregnancy. Steroids can be used if needed. Your team may also add or change a medicine early, to keep you off steroids for long.

Checkups during pregnancy

Even when you feel well, your team will check on your IBD about once each trimester (every 3 months). This usually means:

  • A stool test called calprotectin. It measures inflammation in the bowel. Pregnancy does not change the result, so it is a good test to use now.
  • Blood work. Some results change a little in any pregnancy, and your team knows what to expect.
  • An intestinal ultrasound if needed. It uses no radiation and is safe. It works best in the first two trimesters. Later, the growing uterus can block the view.

A flexible scope can be done in pregnancy if it will change your care. CT scans and MRI with contrast dye are avoided.

Ulcerative colitis is more likely than Crohn’s to flare during pregnancy. In Dr. Squirell’s study, flares in colitis were most common in the middle of pregnancy. So keep your checkups, and call early if symptoms change.

Other things to ask about

  • Low-dose aspirin. It lowers the risk of pre-eclampsia, a serious high blood pressure problem. Ask your obstetrician about starting it at 12 to 16 weeks.
  • Blood clots. IBD raises the risk of blood clots in pregnancy and after birth. If you are in hospital, you may get a blood thinner shot.
  • Vaccines. Non-live vaccines are safe in pregnancy and on IBD medicines. Canada advises these in every pregnancy:
    • The flu shot and a COVID-19 vaccine, at any stage.
    • Tdap, to protect your baby from whooping cough. The best time is 27 to 32 weeks.
    • RSV protection for your baby. RSV is a virus that can cause serious chest infections in babies. You can get an RSV vaccine (Abrysvo) at 28 to 36 weeks. Or your baby can get an RSV antibody shot after birth. Usually one or the other is enough. In Ontario, both are free in RSV season. Ask your team which is best for you.
When each one fits in pregnancyShown in weeks of pregnancy. Your obstetrician or midwife will confirm the timing for you.
  • Flu shot, COVID-19 vaccineAny stage
  • Low-dose aspirin, if advisedStart at 12 to 16 weeks
  • TdapBest at 27 to 32 weeks
  • RSV vaccine (Abrysvo)28 to 36 weeks

Giving birth

Most people with IBD can have a vaginal birth. IBD alone is not a reason for a C-section. A vaginal birth does not cause Crohn’s disease around the bottom.

A planned C-section is usually advised if you have:

  • Active Crohn’s disease around the bottom, such as an abscess or fistula. A fistula is a tunnel from the bowel to the skin or another organ.
  • A fistula into the vagina, now or in the past.
  • A J-pouch. A C-section helps protect the muscles that keep the pouch from leaking. Talk this choice through with your team.

Otherwise, how you give birth depends on the usual reasons your obstetrician uses for anyone.

After your baby is born

Keep taking your IBD medicine. Flares are more common in the months after birth, and they are more common in people who stop their medicine. Plan to keep up your stool tests and blood work in the first year.

Breastfeeding is encouraged. It does not cause flares. Most IBD medicines pass into breast milk in tiny amounts or not at all. You can breastfeed on 5-ASA, azathioprine, steroids, and biologics. Do not breastfeed on JAK pills or S1P pills.

Your baby’s vaccines

If you took a biologic in pregnancy, tell your baby’s doctor or nurse at the first visit.

  • Most vaccines should be given on time. These are the “non-live” vaccines, which cannot cause infection. Babies exposed to biologics respond to them normally.
  • Rotavirus vaccine (drops by mouth, first dose at 2 months). This is a live vaccine. The 2025 expert consensus says it may be given to babies who were exposed to biologics, and we follow that advice. A Canadian study of 191 exposed babies found it was safe. Canada’s national vaccine guide is more cautious. It says there is not enough data yet, and that waiting may be considered. But that advice was written in 2016, before these newer studies. Tell your baby’s doctor about your medicine early. The first dose must be given before your baby is 15 weeks old.
  • BCG vaccine (a tuberculosis vaccine used in some communities). Your baby should not get it in the first 6 months.
  • MMR and chickenpox vaccines at 1 year can be given on the usual schedule.
  • RSV antibody shot (nirsevimab, Beyfortus). This is not a vaccine, and it is not live. It gives your baby ready-made antibodies against RSV. In Ontario, it is free for babies in their first RSV season (fall and winter).
  • Taking a biologic only while breastfeeding does not change your baby’s vaccines.

In Dr. Squirell’s study, babies exposed to biologics had more infections, mostly minor, in their first 6 months. Few needed hospital care. Larger studies of anti-TNF medicine alone have not found more serious infections. Taking anti-TNF medicine together with azathioprine may raise the risk a little. Call your baby’s doctor about any fever or illness, as you would for any baby.

Will my child get IBD?

Most children of a parent with IBD do not get it. The chance is higher if both parents have IBD.

5 to 10 in 100

children get IBD when one parent has it.

About 1 in 3

children get IBD when both parents have it.
Each dot is 1 child in 100. Fainter dots show the range.
Sources for this guide

Sources

  1. Mahadevan U, Seow CH, Barnes EL, et al. Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease. Inflamm Bowel Dis 2025;31(10):2615–64. PMID 40874613 Main source. Also published in Clin Gastroenterol Hepatol 2025;23(11S):S1–S60 (PMID 40874901), J Crohns Colitis 2025;19(8) (PMID 40914850), Aliment Pharmacol Ther 2025;62:1125–80 (PMID 40874657), Am J Gastroenterol 2026;121:31–79 (PMID 40862489) and Gut 2026;75:208–51 (PMID 40876906). Documented remission before conception; active disease raises infertility risk; prior IPAA lowers fertility; stop tofacitinib/upadacitinib ≥4 weeks, ozanimod ≥3 months, etrasimod ≥1–2 weeks before conception; methotrexate stopped ≥1 month (table: 1–3 months) before (these are minimums; the guide uses the clinic's 3 months for all, see Squirell 2024); folic acid 0.4 mg ≥1 month before conception, 2 mg for 3 months before on sulfasalazine, 5 mg with extensive small-bowel disease or malabsorption, and those at increased risk of folate deficiency continue it throughout pregnancy (text and Table 5); continue anti-TNF and anti-IL-23 throughout pregnancy; fecal calprotectin useful in pregnancy; IUS accurate in trimesters 1–2, harder in trimester 3; C-section for active perianal CD and current or past rectovaginal fistula, consider for IPAA; breastfeeding recommended, not on JAK or S1P; low-dose aspirin by 12–16 weeks; higher VTE risk; inactivated infant vaccines on schedule; rotavirus 'may be provided' after in-utero biologic exposure (GRADE 33); avoid BCG for 6 months after anti-TNF exposure (GRADE 34); stopping medicines after birth raised flares.
  2. Squirell E, Meade S, Leung Y. The fundamentals of inflammatory bowel disease management in pregnancy: a practical review for the gastroenterologist. J Can Assoc Gastroenterol 2024;7(1):121–31. PMID 38314178 At least 3 months of steroid-free remission before conception; methotrexate and small molecules stopped 3 months before, so a pregnancy-safe medicine can be started and confirmed (the stop time this guide uses for all four, as Dr. Squirell's clinic practice); calprotectin unaffected by pregnancy, check each trimester; IUS safe in pregnancy; C-section advised for active perianal CD, past rectovaginal fistula or IPAA; most can have vaginal birth; sulfasalazine needs folic acid 2–5 mg; postpartum flares 14–32%; children of a parent with IBD 5–10% risk, about 33% if both parents; rotavirus vaccine: informed discussion.
  3. Squirell E, Rosenfeld G, Bressler B, Meade S, Klemm N, Chen V, Joa E, Leung Y. Pregnant pause? Not for IBD care: a single tertiary care center prospective cohort study affirming IBD management in pregnancy. Crohns Colitis 360 2025;7(2):otaf029. PMID 40401215 287 women, 291 pregnancies (IBD Centre of BC, 2017–2023). 92.7% live births; preterm 6.7% (BC background 8.1%); small for age 7%. Active disease before conception was the strongest predictor of active disease in pregnancy (OR 7.6). UC activity rose to 37% in the 2nd trimester; Crohn's stayed stable. 20% of steroid-exposed babies were born early. Biologic use did not change outcomes. Infants exposed to biologics had more (mostly minor) infections in the first 6 months (25% vs 6.2% after matching).
  4. Fitzpatrick T, Alsager K, Sadarangani M, et al. Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network. Lancet Child Adolesc Health 2023;7(9):648–56. PMID 37390832 191 biologic-exposed infants; rotavirus vaccine recommended for 187; no serious adverse events.
  5. Public Health Agency of Canada. Canadian Immunization Guide, Part 3: Immunization of immunocompromised persons (last partial update September 2026; accessed October 2026). Infants exposed to immunosuppressive biologics in the womb: BCG contraindicated under 6 months; 'no data at this time' on rotavirus vaccine, decide by individual risk-benefit (immune testing may help); where a rotavirus program exists, herd immunity is likely high, so withholding may be considered until more is known; MMR/MMRV at or after 1 year not affected; breastfeeding on a monoclonal antibody has little or no effect on the infant. The CIG table of updates shows this in-utero section, including the rotavirus advice, was added in November 2016; no later entry revises it (the 2026 update added only RSV antibody), and the section cites no study after 2016. It predates Fitzpatrick 2023 and the 2025 consensus, which this guide follows.
  6. Public Health Agency of Canada. Canadian Immunization Guide: table of updates (accessed October 2026). November 2016: immunosuppressive therapy section updated with immunizing infants after exposure to monoclonal antibodies in pregnancy or breastfeeding, including live rotavirus vaccine. Later entries for the chapter (May 2018 revision, 2022, 2023, 2024, September 2026) do not mention rotavirus or in-utero exposure.
  7. Wilson RD, O'Connor DL. Guideline No. 427: Folic acid and multivitamin supplementation for prevention of folic acid-sensitive congenital anomalies. J Obstet Gynaecol Can 2022;44(6):707–19. PMID 35691683 Canadian obstetric guidance (SOGC): a low daily dose of folic acid for everyone who could become pregnant, before conception and through pregnancy and breastfeeding; a higher, two-period regimen for those with medical or surgical conditions that raise the risk of folate deficiency (read from the abstract and published summaries). The 2015 SOGC guideline it replaced gave 1 mg until 12 weeks, then 0.4–1 mg, for moderate risk, which included IBD malabsorption and folate-inhibiting drugs: lower than the IBD consensus doses this guide uses (2 mg on sulfasalazine, 5 mg with malabsorption).
  8. Public Health Agency of Canada. Canadian Immunization Guide, Part 4: Rotavirus vaccine (page updated August 2025; accessed October 2026). Start at 6 weeks and before 15 weeks of age; all doses before 8 months.
  9. Benchimol EI, Tse F, Carroll MW, et al. Canadian Association of Gastroenterology clinical practice guideline for immunizations in patients with IBD — Part 1: Live vaccines. Gastroenterology 2021;161(2):669–80. PMID 33617891 No recommendation for or against live vaccines in the first 6 months for infants of mothers on biologics (evidence insufficient).
  10. Public Health Agency of Canada. Canadian Immunization Guide, Part 3: Immunization in pregnancy and breastfeeding (last partial update August 2026; accessed October 2026). Non-live influenza vaccine in every pregnancy at any stage; COVID-19 vaccine (mRNA preferred) at any stage; Tdap in every pregnancy, ideally 27–32 weeks; RSVpreF at 28–36 weeks before or during RSV season; live vaccines generally contraindicated in pregnancy.
  11. National Advisory Committee on Immunization. Updated guidance to protect infants and children from RSV disease: use of monoclonal antibodies (nirsevimab and clesrovimab) and the RSVpreF vaccine (summary, April 10, 2026). Universal seasonal RSV protection for infants: either an infant monoclonal antibody program (nirsevimab or clesrovimab), or RSVpreF (Abrysvo) at 28–36 weeks of pregnancy plus antibody for higher-risk infants, infants of unvaccinated mothers, and infants born less than 2 weeks after the vaccine.
  12. Ontario Ministry of Health. Respiratory syncytial virus (RSV) prevention programs (updated September 29, 2026). From October 1, 2026: free nirsevimab (Beyfortus, a monoclonal antibody, not a vaccine) for infants born on or after April 1 and under 8 months, and some high-risk children under 24 months; free Abrysvo for pregnant people at 28–36 weeks expected to deliver during RSV season; giving both is generally not recommended, with exceptions.

This guide is for general education. It can't replace advice from your own care team, who know your health history.

Report a problem with this guide

Please don't include patient information. This form isn't for medical questions.

Try “pregnancy”, “Mayo”, “calprotectin” or “VARSITY”.